Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2023
Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022Anne J Huiberts, Brechje de Gier, Christina E Hoeve, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 8, 2024
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024Anne J Huiberts, Christina E Hoeve, Brechje de Gier, et al.Nature Communications|August 9, 2023
Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serologyBrechje de Gier, Anne J Huiberts, Christina E Hoeve, et al.Nature Communications|March 4, 2025
Prospective cohort study of fatigue before and after SARS-CoV-2 infection in the NetherlandsAnne J Huiberts, Siméon de Bruijn, Stijn P Andeweg, et al.BMJ Open|October 14, 2024
Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands - the VAccine Study COVID-19 (VASCO)Anne J Huiberts, Christina E Hoeve, Marjolein N Kooijman, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 22, 2023
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort studyAnne J Huiberts, Brechje de Gier, Christina E Hoeve, et al.The Lancet Regional Health. Europe|December 30, 2025
Post-COVID-19 condition in individuals infected with SARS-CoV-2 in autumn 2023 in the Netherlands: a prospective cohort study with pre- and post-infection dataSiméon de Bruijn, Anne J Huiberts, Stijn P Andeweg, et al.Pageof 2